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Background: There is a lack of effective and affordable technologies to address health needs in the developing
world. One way to address problems of innovation and affordability is to design global health technologies to
follow agreed-upon standards. This Debate article argues that we can better develop standards for global health
technologies if we learn lessons from other industries.
Discussion: The article’s Background section begins by explaining why standards are needed in global health. For
example, if global health technologies can be modularized into independent interfacing parts, these parts can then
interact via well-defined standards in a “plug and play” fashion. This can avoid development of mutually
incompatible solutions by different organizations, speed the pace of innovation, unlock health systems from single
providers and approaches, and lower barriers to entry. The Background then gives a brief primer on standards and
discusses incentives for health standards. The article’s Discussion section begins with brief relevant cases of
standards development from other industries, including electricity, container shipping, CD standards, Universal Serial
Bus (USB), and the Internet. It then explores lessons from these and other industries that suggest how to develop
standards for global health technologies. The remainder of the Discussion considers intellectual property and
regulatory issues and standards-based global health business models, and ends with a checklist of considerations
for health standards development leaders. (The associated Additional file discusses observations from standards
development for cell phones and semiconductors, as well as challenges in the standards development process
itself.) Throughout the article, point-of-care diagnostics are used as an illustrative example. An initiative is already
underway to explore standardized diagnostics platforms.
Summary: This Debate article aims to convince the reader that standards can benefit global health technologies if
we learn lessons from other industries. The article draws from historical examples and the authors’ experiences to
suggest principles, challenges, and opportunities in developing these standards. If implemented well, standardized
platforms can lower barriers to entry, improve affordability, and create a vibrant ecosystem of innovative new
global health technologies.
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The potential of standards for global health technologies
The general problem that motivates this article is the
lack of affordable and effective health technologies to
address key health needs in the developing world. A
wide range of technologies are either available or under
development, including medical devices, diagnostics, drugs,* Correspondence: hassan.masum@utoronto.ca
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reproduction in any medium, provided the ortelemedicine units, prosthetics, mobility aids, health record
and information systems, simulators, maternal and family
health technologies, bednets, and disinfection systems
[1-3]. While there are many examples of such technologies
that have had positive impact on global health, there is still
a strong need for technologies which are more accessible,
socio-culturally appropriate, and effective [4,5].
Developing global health technologies has unique
challenges [6]. Much of the funding for development
and purchase of these technologies comes from founda-
tions and governments, which face immense needs with
constrained resources. The landscape is fragmented, withLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Masum et al. Globalization and Health 2013, 9:49 Page 2 of 12
http://www.globalizationandhealth.com/content/9/1/49many entities creating new technologies. There is a need
for robustness (to function in high-stress environments
with respect to power, heat, dust, vibration, etc.) and sim-
plicity (to be effectively used with minimal training, sup-
port, and repair facilities) [7].
The barriers to development and adoption of needed
new technologies for global health may be classified into
four general categories: scientific (e.g. research capacity),
economic (e.g. low purchasing power), policy (e.g. regu-
latory regimes), and socio-cultural (e.g. issues around
gender or religion) [8]. (We will see later how barriers
from all four categories can hinder the development of
global health technology standards.)
This article first briefly explains in the Background
why global health technologies should be designed to
follow agreed-upon industry-wide interface standards,
and in so doing better address problems of innovation
and affordability. The Discussion then argues that we
can better develop standards for global health technolo-
gies if we learn lessons from other industries.
(By “global health”, we mean health objectives that
transcend national boundaries and aim to improve the
health of people worldwide in an equitable way. Since
most of the population and disease burden of the world
is in lower and middle income countries, global health is
primarily concerned with health issues that are common
in those countries [9].)
As we will see, health technologies can benefit from
standardization for several reasons. If a health technol-
ogy can be “modularized” into independent interfacing
parts, each of these interfacing parts can be improved
or substituted separately. All parts can then interact
according to well-defined interoperability standards.
Along with physical interoperability, standards may also
address “semantic interoperability” – the correct and un-
ambiguous transfer of relevant meaning as data passes
between systems. More generally, standards provide
common principles and norms which can make technology
implementation more efficient and effective.
We will use point-of-care diagnostics for use in develop-
ing countries as an illustrative example throughout this art-
icle [10-13]. (Standardized diagnostics platforms for global
health could lower costs, speed innovation, and save lives.
An initiative with funding from the Bill and Melinda Gates
Foundation and Grand Challenges Canada is underway
[14], with over US$30 M committed.) Medical devices are
another example of interest.
There is a vast literature on the importance of stan-
dards for public policy [15] and for economic and
technological progress [16-18]. For instance, a detailed
German study suggested that standards have a positive
effect on trade, enhance international competitiveness,
and provide societal benefits beyond those to individual
companies [19]. A more recent estimate illustrated theimportance of standards for economic growth in four
European countries and twelve sectors [20], and two
other studies found positive impacts on labor productiv-
ity in Britain [21] and Canada [22].
Open standards do not lock users in to a particular
vendor. They form the basis of the Internet’s innova-
tions, and have been advocated for many applications
such as a smart energy grid, healthcare information sys-
tems, and public and government data [23,24]. We argue
that they can be especially beneficial for health technolo-
gies for the developing world. They can avoid vendor
lock-in, support new modular solutions which interoper-
ate with an installed base of technologies and devices,
and open the door for lower-cost providers (some based
in developing countries themselves) to take part in health
technology innovation without needing to create and
manufacture an entirely new platform.
A brief primer on standards
The British Standards Institution provides this definition
of technological standards: “Put at its simplest, a stand-
ard is an agreed, repeatable way of doing something. It is
a published document that contains a technical specifi-
cation or other precise criteria designed to be used con-
sistently as a rule, guideline, or definition [25].”
Two basic functions of standards are interface (or
compatibility) and quality (or safety). In general terms,
a standard’s interface specifications define how prod-
ucts interoperate with each other or with the rest of the
world. In contrast, a standard’s quality specifications de-
fine product performance against quality or safety met-
rics. Many standards are primarily concerned with one or
the other, and in this case we may speak of an “interface
standard” (or “technical standard”) in contrast to a “qual-
ity standard”.
For health technologies such as drugs and medical de-
vices, regulatory bodies have to date been less concerned
with interface standards than with quality standards –
for example, safety, efficacy, and the issue of counterfeit
drugs [26]. Where not otherwise indicated, this article is
focused on interface standards. A familiar example of an
interface standard is Universal Serial Bus (USB), which
reduced costs and complexity for both consumers and
manufacturers and is discussed in more detail later in
this article.
New health technologies normally require quality stan-
dards as soon as they reach users and patients. In con-
trast, for interface standards premature standardization
and modularity may “lock in” to a suboptimal architec-
ture or interface, which is difficult to displace [27].
When there is no clear understanding of what function-
ality is best, a premature standard can lock technology
developers into an inferior approach and stifle innovation,
or (if the standard is voluntary) simply become a white
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technology that has not been field-tested is likely not
suitable for standardization.
Upgrade paths can be designed in from the start for
standards. Designing health technologies for backward
compatibility requires consideration of which “interface
elements” can stay the same across technology genera-
tions. This allows the internals to change while the inter-
faces do not. For example, a diagnostic platform designer
might change diagnostic algorithms rapidly, while want-
ing to maintain physical “plug-compatibility” across plat-
form generations.
Maturity and backward-compatibility are two criteria for a
good standard. Other criteria include forward-compatibility,
modularity, maintainability, device-independency, inter-
nationality, extensibility, and simplicity [28].
Incentives for global health standards
One might argue that technology developers have often
been motivated to reduce compatibility, in order to main-
tain competitive advantage and lock users into proprietary
offerings. Are there really sufficient counterbalancing in-
centives to create standards for global health technologies?
Fortunately, the answer is yes: there are several incen-
tives to create global health standards. First, appreciation
of the social value of interoperability. Can a convincing
case be made that interoperability and standards will
lead to less expensive and more innovative products for
end users? To more lives saved? An example might be
the expansion of treatment possible if a standardized
platform increases affordability.
Such an argument could attract product developers
who value social returns for their own sake, and for the
sake of the positive publicity and employee motivation
they bring. Substantial public goodwill is enjoyed by
those developing solutions for the poorest.
Second, requirements from buyers. A large buyer can
tip the balance toward one particular standard, or to-
ward standards in general. Global health technologies
are often funded by a few large buyers such as health
ministries or donors. Buyers might prefer standards in
order to avoid lock-in, or to encourage innovation and
cost reductions. Considerations for buyers include mus-
tering sufficient buying power, avoiding preference for a
premature or deficient standard, maintaining good rela-
tions with technology developers, and addressing regula-
tory considerations.
Third, requirements from technology development funders.
Preference for interoperability and standards conform-
ance might become part of the global health funding
toolkit, complementing march-in rights and global access
provisions [29].
It may be difficult to decide whether to exempt a
non-conforming innovative approach from standardsrequirements, such as a cheap and robust paper diagnostic
which cannot readily conform to plug or interface specifi-
cations. Standards should be written with such eventual-
ities in mind. One tactic is to modularize the requirements
themselves, so that one part can remain valid even if an-
other becomes superseded by a new technological ap-
proach (akin to the idea of "severability" in law).
Fourth, lower costs of innovation leading to new techno-
logical and business approaches. Smaller entities can cre-
ate a standards-conforming diagnostic, and license it to
larger entities for scaled-up manufacturing and delivery.
Larger entities can create a standard based on joint tech-
nology, allowing them to spread technology or create a
new market faster.
A lowered cost of innovation enables more diverse
technology creators, including those who may accept
lower profit margins in exchange for greater product dis-
semination and impact. Ultimately, effective standards
can even cause an entire market to grow.
Fifth, open business models. An example is the “open
source” idea which originated in the software world.
This denotes software whose source code is free to exam-
ine, use, or extend, under specified conditions. Open
source has achieved well-known successes like Linux and
Firefox in the software world. Its applications in health
technologies to date are fewer, though there is significant
potential [30,31].
Open standards facilitate collaborative approaches,
which can speed innovation – for diagnostics, perhaps
encouraging collaborative development of common algo-
rithms and user interfaces. An open standard may be
more readily adopted if core implementation pieces are
made available in an open source way [32]. If leading or-
ganizations are willing to open up their technology while
giving up some control, and a “coalition of the willing”
can be instigated, then open business models can help
develop standards and solutions.
Sixth, social and cultural factors. As an example, the
adoption of open source software has been boosted in
some countries by the desire to adapt software to local
needs, become less dependent on imported solutions,
and enable local innovators. Similar incentives may help
“make the case” in developing countries for supporting
standards – especially if this lowers barriers to local in-
novators sharing in health technology value chains.
This Background on global health technology stan-
dards has established how they can be beneficial and
why people might want to create and use them. Next,
the Discussion will explore what we can learn about
standards from other industries.
Discussion
We argue that other industries have much to teach us
about developing global health technology standards.
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nificant health benefits worldwide. If standards lead to
lower-cost health technologies, then a given health budget
can produce more health benefits. And if standards lead to
more rapid innovation in global health technologies, then
the set of health technology options will expand, which
can likewise increase health benefits.
Examples discussed below include electricity, container
shipping, CD standards, Universal Serial Bus (USB), and
the Internet. In the supplementary text file, we explore two
other examples in more depth: cell phones and semicon-
ductors [see Additional file 1].
All these industries suggest how interface standards
and interoperability can assist development of global
health technologies. After the examples, we summarize
lessons for global health technologies, and apply these
lessons to the specific case of point of care diagnostics.
Before discussing lessons from other industries, we
note the tremendous amount of work done over the last
decade in health care technology standards for devices
and data [33]. Examples include device-level standards
(IEEE 11073, Bluetooth) and medical information ex-
change standards (HL7) [34]. Interoperability has been
argued to be critical for exchanging health information
[35], data sharing in research and healthcare [36], and
the use of standards to support clinical research [37].
Many entities have arisen focused on health information
technology standards – some part of established groups
like the IEEE, others stand-alone organizations or con-
sortia [38]. While our focus is on lessons from other in-
dustries (especially those where standards-based global
implementation is at least a decade old, to better distill
durable lessons) we feel that these health technology
standards efforts hold lessons supportive of our general
argument.
Case studies from other industries
The brief standards development case studies in this sec-
tion are drawn from industries in which standards have
led to widespread adoption and innovation for at least a
decade. The cases were chosen to illustrate the evolution
of platforms that are used across an industry, to be well-
documented, and to have lessons germane to global
health technologies.
The cases (and the lessons which follow) are discussed
from both economic and technological viewpoints, illus-
trating incentives and design principles respectively.
Shipping containers: efficiency in a box
From 1958 onward, US and other agencies worked to
end the anarchy of different shipping container dimensions
from different carriers – a variety which complicated logis-
tics and intermodal transfer. The US Maritime Adminis-
tration (MARAD) had significant market power due toboth regulatory authority and provision of subsidies. The
committees tasked with deciding on a standard had
many different proposals, reflecting the interests of pro-
posing parties (e.g. existing container stock, and prefer-
ences depending on where each party normally carried
freight) [39].
A MARAD committee agreed on one set of sizes,
while a defense-related task force decided on other sizes
for military cargo. After a tangled and at times contentious
process involving industry, government, and defense sec-
tors over the next few years, US standards were achieved,
followed by international standards through the ISO
(International Organization for Standardization).
Economic viewpoint: the story illustrates how parties
with buying power can influence standards – a common
situation in global health technologies with large public
or donor buyers. The standards reflected compromises,
but were “good enough” for major parties and enabled
long-term economic gain once accepted. For example,
the cost of loading cargo onto a ship has over the years
dropped by more than 80%, which made international
trade significantly more cost-effective. This helped change
global patterns of economic growth through trade [40].
Technological viewpoint: engineering tests played an
important part in modifying the standard, such as when
corner fittings had to be revised after failing stress tests
simulating conditions in diverse parts of the world. Stan-
dardized shipping containers also enabled process inno-
vations such as intermodal transport without unpacking.
Unanticipated uses arose such as repurposing end-of-life
containers for low-cost housing – a situation replaying it-
self in global health as mobile technologies are repurposed
for health applications.
USB: plug and play
The concept of “platform leadership” has as a tenet the
market leadership possibilities in creating a standard
platform that others build on – a strategy followed by
Cisco, Intel, Microsoft, and others [41]. Such platforms
have sometimes been created as open Intellectual Prop-
erty (IP) spaces where any innovator could make use of
the new standard. An example is the Universal Serial
Bus (USB) standard, for which Intel instigated the devel-
opment process in 1994 with 6 other large companies
including IBM and Microsoft – a small, closed group
where each partner had significant assets and credibility
with the broader market.
Economic viewpoint: getting the USB standard adopted
required marketing and evangelism with diverse industry
participants, including software and hardware developers
and peripheral manufacturers. This marketing was assisted
by uptake from key partners, e.g. Microsoft implementing
USB in its operating system. Such uptake acts as a strong
credibility signal – one which might be sought by parties
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proach taken was to license USB royalty-free to other par-
ties, as opposed to the less stringent RAND (“reasonable
and non-discriminatory”) terms often required by other
standards bodies.
Technological viewpoint: the humble USB plug repre-
sents a remarkable innovation – one that has reduced
complexity and made life easier for everyone who uses a
computer. Before the advent of USB, there were a pleth-
ora of connectors for peripherals. Now, many periph-
erals and devices can be interconnected worldwide using
only one standardized plug – one that also supports
daisy-chaining several devices in a row and recharging.
This high degree of interoperability required strong
specifications and testing, including “plugfests” where
manufacturers gathered to test devices with each other.
Could health technologies be designed with similar inter-
operability and testing?
USB’s innovation platform is now being applied in
novel ways. Examples include powering LED lamps and
charging and communicating with medical devices.
Electricity: a platform for power
When electricity was first being set up as a power source
in the US in the 1880’s, Edison’s DC system battled
Westinghouse’s AC system. This was an early and infam-
ous standards war [42]. Edison and his allies fought to
convince the public that AC was less safe, even promot-
ing an AC current electric chair for electrocution of
criminals.
Economic viewpoint: ongoing innovation in AC and
lower transmission costs helped lead AC to victory over
the earlier DC technology. First-mover advantage can be
overcome when users are not overly entrenched – a con-
sideration when designing health solutions that outper-
form what already exists.
Technological viewpoint: once electricity systems and
plugs were standardized, the electricity “platform” enabled
progress over many decades [43]. Today, standards are be-
ing discussed for future smart energy grids which will en-
able multi-way sharing of information and electricity [44].
Color TV: competing standards
Black and white TV started broadcasting in the US in
1941, but as late as 1963 only 3% of US households had
color TVs. RCA and CBS had competing technologies,
both of which were costly. Technology adoption can be
slow where price relative to performance is unappealing.
Economic viewpoint: the CBS technology was initially
adopted in 1950 as the new color standard because the
RCA technology had technical problems and a higher
price point. It took another decade for color TV sales to
become a large profit center, showing how new stan-
dards can diffuse slowly when existing solutions are “goodenough” and incremental costs are high for buyers – a fac-
tor of particular relevance in the budget-constrained global
health arena.
Technological viewpoint: RCA’s formation of an indus-
try alliance and a standard that would be backward-
compatible with black and white broadcasts helped reverse
the standard in 1953. Similar to the AC-DC electricity bat-
tle, RCA’s technology and partnerships had overcome the
CBS first-mover advantage [45].
Compact discs: domination and repurposing
Compact discs were a digital solution to music storage
that grew to dominate the market. Compact disc stan-
dards were first released in 1980.
Economic viewpoint: Providing a precedent for health
technology developers, Sony and Philips learned from
history and avoided a standards war with compact disc
technology [46]. Their effort was focused on convincing
customers to invest in new players and discs. This en-
abled the market to take off relatively quickly, avoiding a
repeat of the VHS-Betamax videotape standards war
which harmed both consumers and manufacturers. Be-
cause avoiding standards wars can benefit consumers as
well as companies, co-operation on standards can bypass
antitrust laws against collusion.
Technological viewpoint: Sony and Philips worked to-
gether on R&D. Years later, compact disc technology
was repurposed for data storage. Along with providing
large amounts of data storage, this had the additional
benefit of allowing computers to readily read and write
the large “installed base” of music.
The internet: ubiquitous compatibility
The Internet is the ultimate example of the power of
standards and interoperability.
Economic viewpoint: Devices which connect to the
Internet are free to evolve as long as they support network-
ing standards. This suggests that standards for “edge de-
vices” should specify how devices interoperate, but not
what additional functionalities the devices may have. In
contrast, standards for telecommunications companies’
capital-intensive equipment incorporates its long-lived na-
ture. When designing health technologies, aspects which
are meant to endure or interconnect with other technolo-
gies may require tight specifications, but for as little func-
tionality as possible.
The Internet could have evolved very differently. There
were pressures in the 1990’s to create a “Web TV” which
would only access content from a single provider and re-
strict users’ ability to create new content and services.
Ultimately, the power of an open approach won out, illus-
trating the benefits when diverse providers can innovate
with low barriers to entry. Debates today about future stan-
dards – e.g. platforms that are less open but promise more
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change the current open nature of the Internet [47].
Positive network effects also played a critical role. Past
some point, everyone wanted to connect to the Internet
to reach all the other people who were already connected
to the Internet. Those aiming to build new health technol-
ogy platforms might consider how to stimulate interest
and user communities at an early stage.
Technological viewpoint: A key concept in Internet
standards is the idea of a “protocol stack”. Each level
of the stack uses standards which handle some aspect
of data communications or manipulation. Higher-level
standards can be changed independently of lower-level
standards.
For example, the details of how information is traveling –
such as through a fiber-optic cable, a phone wire, or a
wireless connection – are abstracted into the idea of a
communications pipe at the base of the protocol stack.
Functionalities like checking received data for errors and
requesting retransmission of garbled information can then
be defined independently of the particular physical means
of transmission employed. This approach is a powerful
one for standard-setters to implement where possible: de-
fine logically independent layers, each of which interacts
with others only via specified interfaces.
A standards failure related to the Internet was the
X.400 email specification that aimed to interconnect
proprietary email systems. It failed for several reasons:
premature and complex specifications, inadequate first
implementations which may have deterred early adopters,
and lack of incorporation of technical progress into the
standard. The X.400 story illustrates why standard-setting
needs to track technical progress. It also suggests the dan-
gers in complex and all-embracing standards as compared
to more modular and extensible ones [48].
Lessons for global health technologies
This subsection suggests lessons for global health tech-
nologies, drawing from the case studies above (as well as
others in the Additional file and the literature [49,50]). It
applies many of the lessons to point of care diagnostics
as a case example.
While reading the lessons, the reader may wish to
keep in mind several barriers to standardization for glo-
bal heath technologies such as diagnostics and medical
devices. First, the landscape of health technology devel-
opers is fragmented, comprising developers which are
small and large, for-profit and non-profit, and from
higher-income and lower-income countries. This diver-
sity and lack of dominant entities may impede standards
efforts. Second, incentives of for-profit and non-profit
entities may differ – for example, if for-profit companies
foresee higher profits from locking users in to their prod-
uct platform (even if it means users pay more and hencehave less access to health technologies). Third, while qual-
ity standards have long been built into health products,
interface and platform standards are relatively new to the
field. Fourth, the diversity and ongoing evolution of global
health technologies hinders standardization. Fifth, health
needs and delivery systems differ across geographies —
e..g. a point of care test for a remote rural location "under
the tree" must be designed differently from a test for a
health facility with some infrastructure.
Economic viewpoint
Innovation potential: Familiar platforms such as electri-
city and the Internet enabled huge innovation over de-
cades. They also enabled long-term economic gain, and
innovations in business models. A diverse range of con-
tent providers built on the platforms, spurred by low
barriers to entry. For global health technologies where
monetary considerations are important, thought should be
given to incentives for platform innovators. Interest and
user communities should be stimulated at an early stage.
Open platforms: In some cases – the Internet, tele-
phones, TV – it is clear that, after an initial technology
development stage, adopting a single standard can re-
duce complexity and cost and foster efficiencies. Suitable
health technologies might have architectures that can be
modularized and benefit from innovation by diverse par-
ties. A standardized installed base lowers barriers to
entry and allows innovators to create specialized parts of
the modular technology without needing to create an
entire technology platform.
Open platforms and standards could benefit diagnos-
tics. An example is the open Medical Application Plat-
form approach which seeks to provide device and health
information interoperability, safety-critical functionality,
and the ability to run clinical applications—all of which
could offer advantages for safety and effectiveness in
health care delivery (including point of care diagnostics)
[51]. The widespread adoption of open platforms like
this could potentially reduce the duplication of effort
and investment inherent in creating a separate platform
for each medical device.
First-mover advantage: First-mover advantage is im-
portant, especially in markets with strong network ef-
fects where the value of a choice increases as others
make the same choice. However, as illustrated by several
examples, first movers can be displaced by later comers
with superior technology or business strategy – as long
as users are not overly invested in the first mover’s tech-
nology. Having a backward-compatible standard helps.
(An example from global health is the superseding of or-
dinary bednets by long-lasting insecticide treated nets.
The superiority of the latter allowed them to overtake
the former, while the similarity in form factor eased the
transition [52]).
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a new standard can be aided by seeking early adopters,
offering compatibility with other market-leading stan-
dards, and investing to create an installed base of plat-
form users. Bringing partners and customers on board
can be assisted by recruiting prominent allies, evangeliz-
ing, and utilizing peer review and open trials to ensure a
good standard.
Ongoing commitment: Creating health standards and
standardized health technology platforms is not a one-
time investment. If a standard or platform becomes ossi-
fied, imposes too much overhead, or suffers from security
flaws due to its openness, a new player may introduce a
proprietary alternative that provides a superior user experi-
ence. A useful standard evolves in tandem with tech-
nological and economic realities, and requires ongoing
commitment. In the global health field, there may be ten-
sion between this ongoing commitment and the grant-
driven nature of much health technology innovation.
Even large foundations will have to credibly demonstrate
their “staying power” if they wish others to adopt stan-
dards they propose.
Significant benefit: New standards can diffuse slowly
when existing solutions are “good enough” and incre-
mental costs are high. Conversely, if major players create
an improved standard, it can spread quickly. This sug-
gests an important role for large funders to kick-start
health technologies. Even with such support, the standard
should offer significant value increase at an affordable cost
for manufacturers, buyers, and users in the field – and
“cost” can include money, time, and other aspects.
Strategy: As standards develop in an industry, there
are three types of outcome: collaborative adoption of a
single standard, an oligopoly where multiple standards
persist, and a standards war [53]. Many assets come into
play in deciding each party’s strategy: a loyal or locked-
in user base, IP rights, innovation and manufacturing
capability, first-mover advantage, strength in comple-
ments, brand name and reputation, and pressure from
buyers and funders. From a global health point of view,
avoiding competing standards may speed the introduc-
tion of affordable life-saving technologies – but only if
the standard adopted promotes innovation and is widely
deployed.
Rapid uptake: New technologies which do not require
a co-ordinated switchover have had rapid uptake, espe-
cially when immediate benefits are evident. This dy-
namic could aid the adoption of health technologies
which are backward-compatible; which interact with
other parts of the health system through well-defined in-
terfaces; and which can be adopted in a decentralized
way (for example, by different health providers).
An example is the development of a low-cost imaging
solution which is a simple attachment to a cell phone[54]. The attachment is claimed to convert a cell phone
to a microscope which can image both stained and un-
stained blood-smears, allowing diagnosis of clinical path-
ologies. If future iterations of such attachments become
available cheaply with high quality and ease of use, they
might rapidly become widely used in point of care set-
tings around the world—not least because they can be
adopted in a decentralized way with low incremental
cost, rather than requiring entire health systems to switch
over technologies.
Reducing unnecessary costs: Incompatibilities can arise
from “good enough” decisions, yet persist for decades
and require large costs to ultimately reconcile. When
standards are adopted and fail, such as with the Betamax
loss to VHS, those on the losing side eventually write off
their sunk costs and move on. The aggregate losses of
such sunk costs illustrate why a successful standard-
setting process has economic and social benefits: avoiding
unnecessary standards wars reduces unnecessary costs. For
new global health technologies, it will be important to
avoid unproductive standards wars, or cases where a stand-
ard platform is put forth and eventually fails. This in turn
requires effective standard-setting processes.
Technological viewpoint
Effective convergence: An effective standard-setting process
assists convergence to a single standard. This encourages
all parties to incorporate the standard into their product
designs. It also helps ensure that the chosen standard
is well-designed from economic and technological points
of view.
Leapfrogging: Some early standards have failed, such as
early email and color TV technologies. More subtly, suc-
cessful early standards can impede adoption of later
standards. The French Minitel electronic network had
tens of millions of users in the 1990’s, but its large in-
stalled base meant that later the French were relatively
slow to adopt the Internet. Those procuring health tech-
nologies may at times have to decide whether to wait
and adopt a later version of a standard, potentially “leap-
frogging” a lesser-developed earlier version.
Modularity: The Internet’s “protocol stacks” illustrate
a layered form of modularity on which medical devices
might build. Modularity enables subparts to be inno-
vated independently and incrementally, and it helps
mitigate complexity. However, it has been found empir-
ically in several R&D-intensive industries such as semi-
conductor design that there are limits to the modularity
approach in practice. These limits will need to be clari-
fied for global health technologies.
The open platform and modularity lessons suggest that
complexity-reducing modular architectures may ease
entry barriers for creators of new global health technolo-
gies. For example, a new sensing module based on novel
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grated with an existing point-of-care diagnostic device, if
the latter had a modular and interoperable architecture.
Similarly, a series of simple sample preparation modules
capable of processing and concentrating various speci-
men types (e.g. blood, sputum, saliva, stool), each with a
common interface to a generic cartridge for analysis (e.g.
Polymerase Chain Reaction (PCR) of sample DNA) would
make the diagnostic platform more useful and prevent
users in resource-limited settings from having to purchase
multiple single-use diagnostic systems.
Interoperable ecosystems: One can move beyond a sin-
gle device and consider an ecosystem of interoperable
devices. A high degree of interoperability requires strong
specifications and testing, as with USB “plugfests”. If
achieved, it enables technologies to be used in ways that
might not have been originally anticipated. Mobile health
is a familiar global health example of this technology "re-
purposing" [55]. Standard-setting processes for a global
health technology should include sufficient engineering
acumen to implement strong specifications and testing.
An example of interoperability is the growing deploy-
ment of heterogeneous point–of-care diagnostics that
interact with other healthcare infrastructure, to enable
better monitoring, diagnosis, and research [56]. It should
become increasingly possible for devices to interconnect
and share information, without constraining the func-
tionality that each device provides – a strategy that
worked well with telecommunications systems and the
Internet.
Collaboration: Developing standards as part of a larger
consortium or pre-competitive collaboration can miti-
gate risks and avoid inappropriate standards. In the
semiconductor industry, pre-competitive collaboration
was supported through funding long-term initiatives,
linking academia and industry, and motivating talented
people to take part.
For diagnostics, a senior industry source has suggested
realistic ways for firms to collaborate: “Companies could
more widely share the details of their internal quality
systems, enhance standards for reporting adverse events
and corrective actions, standardize the reporting and
handling of incidental findings, and publicize best and
less-than-best practices” [57]. Motivations for such shar-
ing could include regulatory requirements and pressure
from buyers, as has already happened in standardizing
aspects of analysis and reporting. (The same source indi-
cates that other aspects that are competitive differentiators,
such as assays and interpretation formats, would be harder
targets for collaboration).
Technology foresight: Technology road-mapping and
related foresight methods may enable pre-competitive
collaboration for health technologies [58]. They can help in
breaking down a technological challenge into sub-goals,and in envisioning scenarios for which global health tech-
nologies might be designed. Simulations and design
methods can help in making user-centered trade-offs,
and answering questions like: what are the key interfaces
and components? Could point-of-care diagnostic devices
use USB for charging and communication? What are the
product profiles implied by a need for robustness and
simplicity [59]?
Imagine design trade-offs for a standards-based point-
of-care diagnostic. One party might be satisfied with a
cheap and unattractive version, while another might pay
a premium for a small, slick, and rugged version. The
same components might be combined into larger versions,
such as a stationary multi-sample unit able to process
many samples simultaneously. There may be no single de-
vice and modular attachment (e.g. a microfluidic chip)
which meets everyone’s needs, leading to trade-offs and
hard decisions when standardizing. In the course of com-
plex discussions of technology, there is a need for smart
systems architecture thinking – “option mapping” that
clearly lays out design considerations, and facilitates effect-
ive decision-making.
How to develop standards
Thus far we have argued in favor of developing stan-
dards for global health technologies by learning lessons
from standards in other industries. But a skeptical reader
might object that the process of creating global health
technology standards is impractical, involving too many
challenges and unknowns.
In the remainder of the Discussion we therefore dis-
cuss intellectual property and regulatory considerations
and standards-based global health business models, and
end with a checklist of considerations for health stan-
dards developers.
We note that the experiences of some standard-setting
organizations clarify how one might develop health stan-
dards. For example, CLSI (the Clinical and Laboratory
Standards Institute) develops “…globally applicable vol-
untary consensus documents for health care testing”
[60], such as consensus guidelines for analysis and pres-
entation of antimicrobial resistance trends [61]. It has
been selected by WHO as a collaborating center for clinical
laboratory standards, and it has detailed procedures for de-
veloping consensus standards and guidelines [62]. Two
timelines used are 15 and 25 month tracks, with the former
for non-controversial projects with narrow scope. The sup-
plementary text file further explores standards develop-
ment organizations and processes [see Additional file 1].
Intellectual property and regulatory considerations
Standard-setting activities frequently run into IP consid-
erations [63]. For example, a standard may be set and
specified, with parties only afterward learning that one
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tives should discuss IP and confidentiality provisions
with key parties at the start of the process, and learn
from provisions adopted in previous standards efforts.
While patents are often viewed as promoting innovation,
questions have been raised surrounding IP, innovation, and
international development [65,66]. For example, when
should patent protection be relaxed for humanitarian rea-
sons, and what barriers to follow-on innovation might the
IP system itself create? Innovation rests on a public domain
of ideas [67]. Patent pools (consortiums which cross-
license patents related to a particular technology) are be-
ginning to be used to stimulate research in neglected
diseases, allowing both access to technologies and viable
business models [68]. More strategies will be required to
ensure that the IP landscape for health technologies re-
wards innovators while accommodating humanitarian and
economic goals in developing countries [69].
It can be hard to ensure that standards for each com-
ponent of a standards-based solution translate into a
high-quality overall solution. For example, the auto-
motive industry has experienced systems integration
challenges when auto parts from suppliers interact in
unforeseen ways or have subtle flaws that are diffi-
cult to test for [70].
This challenge might be addressed through both a for-
mal testing process, and open test suites against which
manufacturers could verify compliance. Formal testing
can be required by regulatory authorities, or by buyers
who seek higher quality than the regulatory minimum.
Open test suites could be an opportunity for pre-
competitive collaboration, especially if health technolo-
gies certified against these open test suites are favored
by regulatory authorities or large buyers.
Aside from regulatory controls, quality can be pro-
moted via voluntary codes, though some such codes
may set a low quality bar [71]. Quality can also be pro-
moted via reputation systems that allow users to rate the
quality of goods and services, though such systems are
subject to manipulation and inaccuracy [72]. Voluntary
codes and reputation systems may supplement formal
regulation if lower entry barriers draw diverse devel-
opers, as might happen if a standards-based point-of-
care device allows open development of downloadable
diagnostic algorithms.
This “opening up” of a medical device platform raises
many regulatory issues. It has been argued that open
platforms are more vulnerable to attacks and infiltration,
and counter-argued that open platforms invite greater
scrutiny and more rapid patching of weaknesses. The
complexity of computer and device security threats sug-
gests that there are subtle arguments on both sides, and
that the issue will be increasingly important in develop-
ing health technology standards [73].Standards-based global health business models
What do the standards lessons and arguments above imply
about business models for global health technologies?
End users generally have low ability to pay for global
health technologies, which generally have small markets.
In lower-income countries, R&D funding for these tech-
nologies comes mainly from public and donor sectors,
with a small but increasing private-sector contribution.
In higher-income countries, funding comes from gov-
ernments, philanthropies, and technology developers
[74]. As emerging economies grow, their contribution to
health technology funding will increase.
Standards-based platforms may reduce the cost of
entry for health technology developers. They might, for
example, specialize in consumables, modules, or soft-
ware for a diagnostics platform. Ultimately, lower-cost
platforms and components can increase access for popu-
lations which could not afford the previous generation
of more expensive technologies.
Uptake of a global health technology standard may be
affected by its applicability to a higher-income market.
To take an example, low-cost open-standards diagnos-
tics may not displace higher-end diagnostics in higher-
income markets in the short term, as they may not
match performance and functionality. However, new
modular diagnostics platforms may eventually become a
disruptive innovation globally.
Requirements for effective diagnostics in the develop-
ing world have been divided into three cases with no,
minimal, and moderate infrastructure (with point-of-care
diagnostics particularly needed in the first two cases) [75].
To enable better-informed business models, could a shared
use case library be developed?
This might comprise both explicit requirements like
having to function with no or intermittent electricity,
and tacit knowledge like interviews from clinicians sharing
their practical requirements and socio-cultural concerns.
Might this help diagnostics developers to build more ef-
fective devices and businesses based on past experience?
A checklist of considerations for health standards
developers
Developing a useful standard which achieves broad ac-
ceptance poses many difficulties: mustering support, re-
solving interoperability issues, working with installed
technology, and more. Repeating the mistakes of past
standards development efforts should not be one of
these difficulties.
We therefore propose a checklist of considerations for
health standards developers. These questions were devel-
oped iteratively by the authors. We drew from the litera-
ture and arguments summarized in this article, from our
personal standards experiences in health, semiconductor,
and other industries, and from the checklist method that
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drew from the rules of thumb for creating standards which
one of the authors has developed into a book [77].
This checklist does not constitute legal advice.
These considerations are suggestions only.
Before you start:
– Is there a 5-year organizational and financial
commitment from you as the lead party?
– Is there a strong need for a standard? Will the standard
lead to less expensive and more effective health
technologies for end users, and hence more lives saved?
– Have customers/suppliers been identified who will
implement the standard in their products?
– Is the underlying technology sufficiently mature and
field-tested to allow standardization?
– Is someone on your team familiar with the history
and practice of technical standards?
– Has a similar standards effort been tried before? Are
there lessons to learn to avoid pitfalls?
– Are there competitive forces that should be
considered?
– Can you join an existing consortium or other
collaborative effort?
– Will accreditation by a recognized, international
body be required?
– Would technology foresight methods help clarify
challenges, opportunities, and use cases?
– Is the scope of the effort reasonable so as to ensure
its completion in a timely manner?As you develop the standard:
– Have you clarified which aspects of the health
technology are candidates to be standardized,
including technical, business, and regulatory aspects?
– Are there proven technologies that can be used as a
basis for the standard?
– Are leading technical and business perspectives
represented in meetings?
– Are meetings and standard-setting processes
productive, effectively run, and enjoyable?
– Have you clarified Intellectual Property and
confidentiality provisions, and regulatory issues?
– Have best practices been learned from previous
standards efforts?
– Are early adopters, user communities, and general
interest being stimulated at an early stage?




– Do you have public buy-in from key funders and
decision-makers who can accept and promote the
standard?Before finalizing the standard:
– Has constructive criticism been sought from key
stakeholders for the draft standard?
– Is there buy-in from enough parties to make
widespread adoption of the final standard likely?
– Have technical, business, social, and cultural factors
been explored, and risks mitigated?
– Has the standard been tested in the lab, in the field,
and in peer review and credible trials?
– Have regulatory and safety issues been addressed?
– Does the draft standard offer significant value
increase at an affordable cost for manufacturers,
purchasers, and users?
After the standard is finalized:
– Are you (and any key partners) stewarding the
adoption and development of the standard?
– Is field experience gained from implementing the
standard being shared among technology developers
and researchers?
– Are there clear incentives and business models that
support the standard?
– Are there few entry barriers to using the standard,
especially for new implementers?
– Is there a plan to promote, market, and/or advertise
the standard?
– Is there a training program and/or users’ manual
available for new adopters?
– Has the standard enabled more affordable and
effective health technologies?
– Are partnerships with developing countries being
utilized, for both development and delivery of novel
health technologies and standards?
– Have you built in a periodic review process for the
standard, to maintain its relevance as technology,
markets, and health conditions evolve?
We do not claim that this checklist is perfect. (Indeed,
we invite readers to improve it.) But we do believe that
this type of checklist can be useful, and that lessons
from other industries and past standards development
experiences can help to develop global health standards
in the future.
Summary
This article has shown how learning lessons from other
industries can help us develop standards for global
health technologies. We have explained why standards
are needed in global health, given a brief primer on
standards, and examined incentives to create and use
standards. We then explored lessons from other indus-
tries, considered the standards development process
and standards-based business models, and gave a sug-
gested checklist of considerations for health standards
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as an illustrative example throughout the article.
The development of mutually incompatible solutions
by different organizations can slow the pace of innovation,
lock health systems into single providers and approaches,
and keep barriers to entry high. These problems can
be mitigated by effective standards. In diagnostics and
other global health technologies, standards help enable
innovation and affordability.
Experience from other industries suggests that global
health technologies conforming to well-chosen standards
can enable new entrants and lower price points, link
islands of innovation, and create vibrant solution ecosys-
tems. Realizing this potential requires support from di-
verse stakeholders.
R&D funders and global health organizations can pro-
vide leadership and funds. Policy-makers can support
standards-based approaches. Technology developers can
consider interoperable approaches, and look for oppor-
tunities to interconnect with existing technology compo-
nents. Those in charge of procurement can pressure
suppliers to provide interoperable and modular solu-
tions. Suppliers can in turn design technologies to be
interoperable, engage in pre-competitive collaboration,
and try more open business models where feasible.
We believe that point-of-care diagnostics can be one of
the first global health technologies that benefits from this
approach at global scale – especially if lessons are learned
from other industries. By 2025, could a diagnostics revolu-
tion have as much impact on worldwide healthcare as the
cell phone did on worldwide communications? Could
other global health technologies follow suit? The health
needs of the 21st century demand nothing less.Additional file
Additional file 1: Insights from two additional cases of standards,
and discussion of the standards development process.
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